| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |